An engineered three-in-one hybrid nanosystem from elastin-like polypeptides for enhanced cancer suppression
- 26 October 2022
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 220
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Evaluation of the use of therapeutic peptides for cancer treatmentJournal of Biomedical Science, 2017
- Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cellsJournal of Drug Targeting, 2017
- From amino acid sequence to bioactivity: The biomedical potential of antitumor peptidesProtein Science, 2016
- Effect of ELP Sequence and Fusion Protein Design on Concentrated Solution Self-AssemblyBiomacromolecules, 2016
- Elastin-like polypeptides in drug deliveryAdvanced Drug Delivery Reviews, 2016
- A Highly Elastic and Rapidly Crosslinkable Elastin‐Like Polypeptide‐Based Hydrogel for Biomedical ApplicationsAdvanced Functional Materials, 2015
- Topological Effects on Globular Protein‐ELP Fusion Block Copolymer Self‐AssemblyAdvanced Functional Materials, 2014
- PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancerOncogene, 2013
- Protein-based nanocarriers as promising drug and gene delivery systemsJournal of Controlled Release, 2012
- Peptide and protein drug delivery to and into tumors: challenges and solutionsDrug Discovery Today, 2003